Arkolith/Insider Trading/XLO/Form 4

Luptakova Katarina

CHIEF MEDICAL OFFICERXilio Therapeutics, Inc. (XLO) · full profile →Form 4 · filed Nov 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
0 non-derivative · 11 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 21, 2025Grant(A)106K——106K
Nov 21, 2025Grant(A)44K——44K
Nov 21, 2025Disposed to issuer(D)44K——0
Nov 21, 2025Grant(A)625K—$0625K
Nov 21, 2025Disposed to issuer(D)106K——0
Nov 21, 2025Disposed to issuer(D)15K——0
Nov 21, 2025Disposed to issuer(D)25K——0
Nov 21, 2025Grant(A)35K——35K
Nov 21, 2025Disposed to issuer(D)35K——0
Nov 21, 2025Grant(A)15K——15K
Nov 21, 2025Grant(A)25K——25K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-297205) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML